))
Leqembi: Five insights on the first fully approved Alzheimer's drug
Manage episode 371292259 series 2793637
Konten disediakan oleh David E. Williams. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh David E. Williams atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Leqembi was just approved to treat early stage Alzheimer's. In this solo episode, host David Williams shares five thoughts.
- Leqembi is just different enough from Aduhelm to survive scrutiny
- Patient registry requirement is a good idea
- The delivery system isn't ready
- Health equity will suffer
- Public health and prevention would be money better spent
Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.
186 episode
Bagikan
